Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

100 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature.
Dennett SL, Boye KS, Yurgin NR. Dennett SL, et al. Among authors: boye ks. Value Health. 2008 May-Jun;11(3):478-86. doi: 10.1111/j.1524-4733.2007.00260.x. Value Health. 2008. PMID: 18489671 Review.
Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes.
Ray JA, Boye KS, Yurgin N, Valentine WJ, Roze S, McKendrick J, Tucker DM, Foos V, Palmer AJ. Ray JA, et al. Among authors: boye ks. Curr Med Res Opin. 2007 Mar;23(3):609-22. doi: 10.1185/030079907X178685. Curr Med Res Opin. 2007. PMID: 17355742 Clinical Trial.
Utilities and disutilities for type 2 diabetes treatment-related attributes.
Matza LS, Boye KS, Yurgin N, Brewster-Jordan J, Mannix S, Shorr JM, Barber BL. Matza LS, et al. Among authors: boye ks. Qual Life Res. 2007 Sep;16(7):1251-65. doi: 10.1007/s11136-007-9226-0. Epub 2007 Jul 19. Qual Life Res. 2007. PMID: 17638121
Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change.
Matza LS, Yurgin N, Boye KS, Malley K, Shorr JM. Matza LS, et al. Among authors: boye ks. Curr Med Res Opin. 2007 Sep;23(9):2051-62. doi: 10.1185/030079907X219454. Curr Med Res Opin. 2007. PMID: 17651535
Validation of two generic patient-reported outcome measures in patients with type 2 diabetes.
Matza LS, Boye KS, Yurgin N. Matza LS, et al. Among authors: boye ks. Health Qual Life Outcomes. 2007 Jul 31;5:47. doi: 10.1186/1477-7525-5-47. Health Qual Life Outcomes. 2007. PMID: 17672906 Free PMC article.
Health utility values associated with diabetic retinopathy.
Lloyd A, Nafees B, Gavriel S, Rousculp MD, Boye KS, Ahmad A. Lloyd A, et al. Among authors: boye ks. Diabet Med. 2008 May;25(5):618-24. doi: 10.1111/j.1464-5491.2008.02430.x. Epub 2008 Mar 13. Diabet Med. 2008. PMID: 18346157 Review.
A modeled economic evaluation comparing atomoxetine with stimulant therapy in the treatment of children with attention-deficit/hyperactivity disorder in the United Kingdom.
Cottrell S, Tilden D, Robinson P, Bae J, Arellano J, Edgell E, Aristides M, Boye KS. Cottrell S, et al. Among authors: boye ks. Value Health. 2008 May-Jun;11(3):376-88. doi: 10.1111/j.1524-4733.2007.00256.x. Value Health. 2008. PMID: 18489664
The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy.
Matza LS, Rousculp MD, Malley K, Boye KS, Oglesby A. Matza LS, et al. Among authors: boye ks. Health Qual Life Outcomes. 2008 Nov 7;6:95. doi: 10.1186/1477-7525-6-95. Health Qual Life Outcomes. 2008. PMID: 18992161 Free PMC article. Clinical Trial.
[The impact of obesity in the management and evolution of diabetes mellitus].
Dilla T, Costi M, Boye KS, Reviriego J, Yurgin N, Badia X, Lara-SuriƱach N. Dilla T, et al. Among authors: boye ks. Rev Clin Esp. 2008 Oct;208(9):437-43. doi: 10.1157/13127604. Rev Clin Esp. 2008. PMID: 19000471 Spanish.
Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities.
Zhao Y, Ye W, Boye KS, Holcombe JH, Swindle R. Zhao Y, et al. Among authors: boye ks. Diabet Med. 2009 Jan;26(1):61-9. doi: 10.1111/j.1464-5491.2008.02616.x. Diabet Med. 2009. PMID: 19125762
100 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback